sulfasalazine has been researched along with Diseases of Immune System in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gheorghiu, T | 1 |
| Frotz, H | 1 |
| Ziegler, K | 1 |
2 other studies available for sulfasalazine and Diseases of Immune System
| Article | Year |
|---|---|
[Ulcerative colitis].
Topics: Acute Disease; Adult; Aged; Chronic Disease; Colitis, Ulcerative; Colonic Neoplasms; Diagnosis, Diff | 1973 |
[Clinical aspects and therapy of ulcerative colitis].
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Diagnosis, Differential; Gastric Juice; Germany, East; | 1969 |